Relationship between Interferon Beta-1A Administration and Intracranial Vascular Tone Regulation in Patients with Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Interferon beta (IFN-β) therapy is one of the most commonly prescribed immunomodulatory therapies in relapsing-remitting multiple sclerosis (RRMS). A reversible cerebral vasoconstriction syndrome (RCVS), associated with IFN-β use, has been recently described. For this reason, we tested the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dattola, Vincenzo, Bonanno, Lilla, Naro, Antonino, Chillura, Antonino, Logiudice, Anna Lisa, Sessa, Edoardo, Famà, Fausto, Quartarone, Angelo, Calabrò, Rocco Salvatore, Marino, Silvia, Russo, Margherita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615979/
https://www.ncbi.nlm.nih.gov/pubmed/29057262
http://dx.doi.org/10.1155/2017/5421416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615979/
https://www.ncbi.nlm.nih.gov/pubmed/29057262
http://dx.doi.org/10.1155/2017/5421416

Ejemplares similares